NL180420C - Farmaceutische preparaten, welke een invloed op de maagzuurafscheiding bezitten en ten minste een guanidinothiazoolderivaat als werkzame stof bevatten alsmede de voor gebruik in dergelijke preparaten geschikte guanidinothiazoolderivaten. - Google Patents
Farmaceutische preparaten, welke een invloed op de maagzuurafscheiding bezitten en ten minste een guanidinothiazoolderivaat als werkzame stof bevatten alsmede de voor gebruik in dergelijke preparaten geschikte guanidinothiazoolderivaten.Info
- Publication number
- NL180420C NL180420C NLAANVRAGE7909321,A NL7909321A NL180420C NL 180420 C NL180420 C NL 180420C NL 7909321 A NL7909321 A NL 7909321A NL 180420 C NL180420 C NL 180420C
- Authority
- NL
- Netherlands
- Prior art keywords
- guanidinothiazole
- preparations
- divers
- influence
- contain
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D277/38—Nitrogen atoms
- C07D277/44—Acylated amino or imino radicals
- C07D277/48—Acylated amino or imino radicals by radicals derived from carbonic acid, or sulfur or nitrogen analogues thereof, e.g. carbonylguanidines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D277/38—Nitrogen atoms
- C07D277/40—Unsubstituted amino or imino radicals
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Thiazole And Isothizaole Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP54098906A JPS6056143B2 (ja) | 1979-08-02 | 1979-08-02 | アミジン誘導体ならびにその製造法 |
JP9890679 | 1979-08-02 |
Publications (3)
Publication Number | Publication Date |
---|---|
NL7909321A NL7909321A (nl) | 1981-02-04 |
NL180420B NL180420B (nl) | 1986-09-16 |
NL180420C true NL180420C (nl) | 1987-02-16 |
Family
ID=14232166
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NLAANVRAGE7909321,A NL180420C (nl) | 1979-08-02 | 1979-12-27 | Farmaceutische preparaten, welke een invloed op de maagzuurafscheiding bezitten en ten minste een guanidinothiazoolderivaat als werkzame stof bevatten alsmede de voor gebruik in dergelijke preparaten geschikte guanidinothiazoolderivaten. |
NL930038C NL930038I2 (nl) | 1979-08-02 | 1993-05-19 | Farmaceutische preparaten, welke een invloed op demaagzuurafscheiding bezitten en ten minste een qu anidinothiazoolderivaat als werkzame stof bevattenalsmede de voor gebruik in dergelijke preparaten geschikte quanidinothiazoolderivaten. |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NL930038C NL930038I2 (nl) | 1979-08-02 | 1993-05-19 | Farmaceutische preparaten, welke een invloed op demaagzuurafscheiding bezitten en ten minste een qu anidinothiazoolderivaat als werkzame stof bevattenalsmede de voor gebruik in dergelijke preparaten geschikte quanidinothiazoolderivaten. |
Country Status (12)
Country | Link |
---|---|
US (1) | US4283408A (ja) |
JP (1) | JPS6056143B2 (ja) |
CA (2) | CA1134836A (ja) |
CH (1) | CH648027A5 (ja) |
DE (1) | DE2951675C2 (ja) |
ES (1) | ES8100281A1 (ja) |
FR (1) | FR2462431B1 (ja) |
GB (1) | GB2055800B (ja) |
IT (1) | IT1119641B (ja) |
NL (2) | NL180420C (ja) |
PH (1) | PH15657A (ja) |
SE (1) | SE444317B (ja) |
Families Citing this family (91)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
NZ186965A (en) * | 1977-04-20 | 1980-02-21 | Ici Ltd | Guanidino derivatives and pharmaceutical compositions |
PH16099A (en) * | 1979-03-06 | 1983-06-24 | Yamanouchi Pharma Co Ltd | Guanidinothiazole compounds,process for preparing them and medical composition containing them |
GR71929B (ja) * | 1979-11-13 | 1983-08-19 | Ici Ltd | |
DE3168031D1 (en) * | 1980-07-30 | 1985-02-14 | Ici Plc | Guanidine derivatives |
US4382090A (en) * | 1980-10-02 | 1983-05-03 | Eli Lilly And Company | N-Thiazolylmethylthioalkyl-N'alkylamidines and related compounds |
IN158869B (ja) * | 1981-03-18 | 1987-02-07 | Ici Plc | |
EP0067508B1 (en) * | 1981-05-18 | 1985-10-30 | Imperial Chemical Industries Plc | Amidine derivatives |
DE3238867A1 (de) * | 1982-10-20 | 1984-04-26 | Ludwig Heumann & Co GmbH, 8500 Nürnberg | Heterocyclische verbindungen, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel |
JPS59104370A (ja) * | 1982-12-03 | 1984-06-16 | Kotobuki Seiyaku Kk | チアゾ−ル誘導体及びその製造方法 |
JPS59227870A (ja) * | 1983-06-07 | 1984-12-21 | Yamanouchi Pharmaceut Co Ltd | 新規2−グアニジノチアゾリン誘導体ならびにその製造法 |
US4497810A (en) * | 1983-10-14 | 1985-02-05 | Merck & Co., Inc. | Thiatriazine dioxides as gastric anti-secretory agents |
US4663347A (en) | 1983-10-31 | 1987-05-05 | Merck Frosst Canada, Inc. | Benzofuran 2-carboxylic acid esters useful as inhibitors of leukotriene biosynthesis |
CA1269382A (en) * | 1984-04-18 | 1990-05-22 | Jose A. Ortiz | Anti-ulceric sulfonamidines |
US4560690A (en) * | 1984-04-30 | 1985-12-24 | Pfizer Inc. | 2-(N-substituted guanidino)-4-hetero-arylthiazole antiulcer agents |
JPS6160673A (ja) * | 1984-08-30 | 1986-03-28 | Yamanouchi Pharmaceut Co Ltd | グアニジノチアゾ−ル誘導体の製造法 |
CA1309557C (en) | 1985-06-18 | 1992-10-27 | Robert N. Young | Leukotriene antagonists |
HU194845B (en) * | 1985-09-11 | 1988-03-28 | Richter Gedeon Vegyeszet | Process for production of n-sulphamil-3-/2-guanidintiazolil-4-methil-tio/-propion-amidin |
EP0239306B1 (en) | 1986-03-27 | 1993-06-02 | Merck Frosst Canada Inc. | Tetrahydrocarbazole esters |
DE3644246A1 (de) * | 1986-06-20 | 1987-12-23 | Uriach & Cia Sa J | Verfahren zur herstelung von 3-(((2-((aminoiminomethyl)-amino)-4-thiazolyl)-methyl)-thio)-n-(aminosulfonyl)-propanimidamid |
HU196775B (en) * | 1986-08-05 | 1989-01-30 | Richter Gedeon Vegyeszet | Process for production of morfologically unique new modifications of famotidin and medical compositions containing such substances |
ES2008810A6 (es) * | 1988-07-18 | 1989-08-01 | Marga Investigacion | Procedimiento de preparacion de derivados de n-sulfamil-propionamidina. |
HUT61980A (en) | 1990-10-12 | 1993-03-29 | Merck Frosst Canada Inc | Process for producing saturated hydroxyalkylquinoline acids and pharmaceutical compositions comprising such compounds as active ingredient |
US5294433A (en) * | 1992-04-15 | 1994-03-15 | The Procter & Gamble Company | Use of H-2 antagonists for treatment of gingivitis |
CA2110313C (en) * | 1992-12-01 | 2004-10-26 | Edward John Roche | Pharmaceutical compositions containing a guanidinothiazole compound and antacids |
US5410054A (en) * | 1993-07-20 | 1995-04-25 | Merck Frosst Canada, Inc. | Heteroaryl quinolines as inhibitors of leukotriene biosynthesis |
US5593696A (en) * | 1994-11-21 | 1997-01-14 | Mcneil-Ppc, Inc. | Stabilized composition of famotidine and sucralfate for treatment of gastrointestinal disorders |
US5650421A (en) * | 1995-03-31 | 1997-07-22 | Baxter International Inc. | Premixed famotidine formulation |
US5667794A (en) * | 1995-05-02 | 1997-09-16 | Merck & Co., Inc. | Heartburn treatment |
US5854267A (en) * | 1995-06-02 | 1998-12-29 | Merck & Co., Inc. | Method for preventing heartburn |
KR0168978B1 (ko) * | 1995-07-12 | 1999-01-15 | 김종인 | 헤테로고리 접합 티아졸 유도체 |
US5989588A (en) * | 1996-10-04 | 1999-11-23 | Merck & Co., Inc. | Methods and compositions for preventing and treating heartburn |
US6949264B1 (en) | 1996-11-27 | 2005-09-27 | Wm. Wrigley Jr. Company | Nutraceuticals or nutritional supplements and method of making |
US5856500A (en) * | 1997-03-11 | 1999-01-05 | Albemarle Corporation | Synthesis of thiazole derivatives |
US5731442A (en) * | 1997-03-11 | 1998-03-24 | Albemarle Corporation | Synthesis of thiazole derivatives |
JP2002529503A (ja) * | 1998-11-17 | 2002-09-10 | ニトロメッド,インク. | ニトロソ化及びニトロシル化h2リセプターアンタゴニスト化合物及び組成物並びにその利用方法 |
US7163705B2 (en) | 1998-12-15 | 2007-01-16 | Wm. Wrigley Jr. Company | Coated chewing gum product and method of making |
US6586023B1 (en) | 1998-12-15 | 2003-07-01 | Wm. Wrigley Jr. Company | Process for controlling release of active agents from a chewing gum coating and product thereof |
US6531114B1 (en) | 1999-04-06 | 2003-03-11 | Wm. Wrigley Jr. Company | Sildenafil citrate chewing gum formulations and methods of using the same |
US6627234B1 (en) | 1998-12-15 | 2003-09-30 | Wm. Wrigley Jr. Company | Method of producing active agent coated chewing gum products |
US6270807B1 (en) | 1999-03-02 | 2001-08-07 | L. Perrigo Company | Taste-masked pharmaceutical composition |
US6322806B1 (en) | 1999-04-06 | 2001-11-27 | Wm. Wrigley Jr. Company | Over-coated chewing gum formulations including tableted center |
US6773716B2 (en) | 1999-04-06 | 2004-08-10 | Wm. Wrigley Jr. Company | Over-coated chewing gum formulations |
US7935362B2 (en) | 1999-04-06 | 2011-05-03 | Wm. Wrigley Jr. Company | Over-coated product including consumable center and medicament |
RU2001126555A (ru) * | 1999-04-06 | 2003-06-20 | Вм. Ригли Дж. Компани (Us) | Составы фармацевтической жевательной резинки |
US6355265B1 (en) | 1999-04-06 | 2002-03-12 | Wm. Wrigley Jr. Company | Over-coated chewing gum formulations |
US6541048B2 (en) | 1999-09-02 | 2003-04-01 | Wm. Wrigley Jr. Company | Coated chewing gum products containing an acid blocker and process of preparing |
US6645535B2 (en) | 1999-09-02 | 2003-11-11 | Wm. Wrigley Jr. Company | Method of making coated chewing gum products containing various antacids |
US6569472B1 (en) | 2000-09-01 | 2003-05-27 | Wm. Wrigley Jr. Company | Coated chewing gum products containing antacid and method of making |
US6663849B1 (en) | 2000-09-01 | 2003-12-16 | Wm. Wrigley Jr. Company | Antacid chewing gum products coated with high viscosity materials |
WO2001021147A1 (en) | 1999-09-20 | 2001-03-29 | Mastercare | Diet and weight control gum and sucker |
US9387168B2 (en) | 1999-09-20 | 2016-07-12 | Jack Barreca | Chewing gum with tomatidine |
US9253991B2 (en) | 1999-09-20 | 2016-02-09 | Jack Barreca | Chewing gum with B vitamins |
US7115288B2 (en) | 2000-06-09 | 2006-10-03 | Wm. Wrigley Jr. Company | Method for making coated chewing gum products with a coating including an aldehyde flavor and a dipeptide sweetener |
US6572900B1 (en) | 2000-06-09 | 2003-06-03 | Wm. Wrigley, Jr. Company | Method for making coated chewing gum products including a high-intensity sweetener |
US6444241B1 (en) | 2000-08-30 | 2002-09-03 | Wm. Wrigley Jr. Company | Caffeine coated chewing gum product and process of making |
US6579545B2 (en) | 2000-12-22 | 2003-06-17 | Wm. Wrigley Jr. Company | Coated chewing gum products containing an antigas agent |
SE0101379D0 (sv) * | 2001-04-18 | 2001-04-18 | Diabact Ab | Komposition som hämmar utsöndring av magsyra |
SE0203065D0 (sv) | 2002-10-16 | 2002-10-16 | Diabact Ab | Gastric acid secretion inhibiting composition |
TW200517114A (en) | 2003-10-15 | 2005-06-01 | Combinatorx Inc | Methods and reagents for the treatment of immunoinflammatory disorders |
US8980894B2 (en) | 2004-03-25 | 2015-03-17 | Boehringer Ingelheim Vetmedica Gmbh | Use of PDE III inhibitors for the treatment of asymptomatic (occult) heart failure |
EP1579862A1 (en) | 2004-03-25 | 2005-09-28 | Boehringer Ingelheim Vetmedica Gmbh | Use of PDE III inhibitors for the reduction of heart size in mammals suffering from heart failure |
WO2006071659A1 (en) * | 2004-12-29 | 2006-07-06 | Trustees Of Boston University | Delivery of h2 antagonists |
US20080021078A1 (en) * | 2006-07-18 | 2008-01-24 | Horizon Therapeutics, Inc. | Methods and medicaments for administration of ibuprofen |
US8067451B2 (en) * | 2006-07-18 | 2011-11-29 | Horizon Pharma Usa, Inc. | Methods and medicaments for administration of ibuprofen |
US20080020040A1 (en) * | 2006-07-18 | 2008-01-24 | Horizon Therapeutics, Inc. | Unit dose form for administration of ibuprofen |
NZ565846A (en) * | 2005-07-18 | 2011-12-22 | Horizon Therapeutics Inc | Medicaments containing famotidine and ibuprofen and administration of same |
CN101355876B (zh) | 2005-11-09 | 2012-09-05 | 康宾纳特克斯公司 | 一种适用于眼部给药的组合物 |
AU2007275360B2 (en) | 2006-07-18 | 2013-05-16 | Horizon Medicines Llc | Methods and medicaments for administration of ibuprofen |
US8067033B2 (en) | 2007-11-30 | 2011-11-29 | Horizon Pharma Usa, Inc. | Stable compositions of famotidine and ibuprofen |
EP2063873A2 (en) * | 2006-08-31 | 2009-06-03 | Horizon Therapeutics, Inc. | Nsaid dose unit formulations with h2-receptor antagonists and methods of use |
EP1920785A1 (en) | 2006-11-07 | 2008-05-14 | Boehringer Ingelheim Vetmedica Gmbh | Liquid preparation comprising a complex of pimobendan and cyclodextrin |
US7718649B1 (en) | 2006-11-10 | 2010-05-18 | Pisgah Labs, Inc. | Physical states of a pharmaceutical drug substance |
US8039461B1 (en) | 2006-11-10 | 2011-10-18 | Pisgah Laboratories, Inc. | Physical states of a pharmaceutical drug substance |
US20090069395A1 (en) * | 2007-09-09 | 2009-03-12 | Protia, Llc | Deuterium-enriched famotidine |
HUE029444T2 (en) | 2008-01-04 | 2017-02-28 | Schabar Res Ass Llc | A composition containing an analgesic and an antihistamine |
US8883863B1 (en) | 2008-04-03 | 2014-11-11 | Pisgah Laboratories, Inc. | Safety of psuedoephedrine drug products |
WO2010021681A2 (en) * | 2008-08-18 | 2010-02-25 | Combinatorx (Singapore) Pte. Ltd. | Compositions and methods for treatment of viral diseases |
AR078225A1 (es) | 2009-05-11 | 2011-10-26 | Agraquest Inc | Compuestos derivados de hongos muscodor |
US20110130711A1 (en) * | 2009-11-19 | 2011-06-02 | Follica, Inc. | Hair growth treatment |
EP2825159B1 (en) | 2012-03-15 | 2022-06-22 | Boehringer Ingelheim Vetmedica GmbH | Pharmaceutical tablet formulation for the veterinary medical sector, method of production and use thereof |
WO2015002150A1 (ja) * | 2013-07-03 | 2015-01-08 | 株式会社新日本科学 | 新規化合物,有機カチオントランスポーター3の検出剤及び活性阻害剤 |
ES2860526T3 (es) | 2013-07-19 | 2021-10-05 | Boehringer Ingelheim Vetmedica Gmbh | Derivados de ciclodextrina eterificada conservados que contienen una composición farmacéutica acuosa líquida |
PL2925305T3 (pl) | 2013-12-04 | 2017-07-31 | Boehringer Ingelheim Vetmedica Gmbh | Ulepszone kompozycje farmaceutyczne pimobendanu |
EP2929884A1 (en) | 2014-04-11 | 2015-10-14 | Sanovel Ilac Sanayi ve Ticaret A.S. | Pharmaceutical combinations of dabigatran and h2-receptor antagonists |
WO2015163832A1 (en) | 2014-04-25 | 2015-10-29 | Pharmacti̇ve İlaç Sanayi̇ Ve Ti̇caret A.Ş. | An ibuprofen and famotidine combined composition having improved stability |
WO2015169957A1 (en) | 2014-05-09 | 2015-11-12 | Sanovel Ilac Sanayi Ve Ticaret A.S. | Pharmaceutical combinations of rivaroxaban and h2-receptor antagonists |
US10537570B2 (en) | 2016-04-06 | 2020-01-21 | Boehringer Ingelheim Vetmedica Gmbh | Use of pimobendan for the reduction of heart size and/or the delay of onset of clinical symptoms in patients with asymptomatic heart failure due to mitral valve disease |
TR201618765A2 (tr) | 2016-12-16 | 2018-07-23 | Imuneks Farma Ilac Sanayi Ve Ticaret Anonim Sirketi | Ağrı ve enflamasyonun tedavisi için steroid olmayan anti-enflamatuvar ilaçlar ve H2 reseptörü antagonisti kombinasyonları. |
EP4181912A1 (en) | 2020-07-15 | 2023-05-24 | Schabar Research Associates LLC | Unit oral dose compositions composed of ibuprofen and famotidine for the treatment of acute pain and the reduction of the severity and/or risk of heartburn |
US11324727B2 (en) | 2020-07-15 | 2022-05-10 | Schabar Research Associates, Llc | Unit oral dose compositions composed of naproxen sodium and famotidine for the treatment of acute pain and the reduction of the severity of heartburn and/or the risk of heartburn |
US20230349922A1 (en) | 2020-08-11 | 2023-11-02 | Université De Strasbourg | H2 Blockers Targeting Liver Macrophages for the Prevention and Treatment of Liver Disease and Cancer |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB1338169A (en) * | 1971-03-09 | 1973-11-21 | Smith Kline French Lab | Ureas thioureas and guanidines |
NZ186965A (en) * | 1977-04-20 | 1980-02-21 | Ici Ltd | Guanidino derivatives and pharmaceutical compositions |
US4165378A (en) * | 1977-04-20 | 1979-08-21 | Ici Americas Inc. | Guanidine derivatives of imidazoles and thiazoles |
-
1979
- 1979-08-02 JP JP54098906A patent/JPS6056143B2/ja not_active Expired
- 1979-12-20 GB GB7943945A patent/GB2055800B/en not_active Expired
- 1979-12-21 DE DE2951675A patent/DE2951675C2/de not_active Expired
- 1979-12-21 SE SE7910568A patent/SE444317B/sv not_active IP Right Cessation
- 1979-12-21 PH PH23454A patent/PH15657A/en unknown
- 1979-12-24 CH CH11362/79A patent/CH648027A5/de not_active IP Right Cessation
- 1979-12-27 NL NLAANVRAGE7909321,A patent/NL180420C/xx not_active IP Right Cessation
- 1979-12-27 US US06/107,629 patent/US4283408A/en not_active Expired - Lifetime
- 1979-12-28 ES ES487381A patent/ES8100281A1/es not_active Expired
- 1979-12-28 CA CA000342699A patent/CA1134836A/en not_active Expired
- 1979-12-28 FR FR797931938A patent/FR2462431B1/fr not_active Expired
- 1979-12-28 IT IT69498/79A patent/IT1119641B/it active Protection Beyond IP Right Term
-
1986
- 1986-10-31 CA CA000521982A patent/CA1222763B/en not_active Expired
-
1993
- 1993-05-19 NL NL930038C patent/NL930038I2/nl unknown
Also Published As
Publication number | Publication date |
---|---|
ES487381A0 (es) | 1980-11-01 |
JPS5622770A (en) | 1981-03-03 |
FR2462431A1 (fr) | 1981-02-13 |
CA1134836A (en) | 1982-11-02 |
JPS6056143B2 (ja) | 1985-12-09 |
NL930038I1 (nl) | 1993-08-02 |
ES8100281A1 (es) | 1980-11-01 |
SE7910568L (sv) | 1981-02-03 |
CA1222763B (en) | 1987-06-09 |
US4283408A (en) | 1981-08-11 |
NL930038I2 (nl) | 1993-10-01 |
DE2951675A1 (de) | 1981-02-05 |
NL180420B (nl) | 1986-09-16 |
CH648027A5 (de) | 1985-02-28 |
DE2951675C2 (de) | 1982-07-01 |
NL7909321A (nl) | 1981-02-04 |
IT1119641B (it) | 1986-03-10 |
GB2055800B (en) | 1983-05-11 |
FR2462431B1 (fr) | 1985-07-26 |
IT7969498A0 (it) | 1979-12-28 |
PH15657A (en) | 1983-03-11 |
SE444317B (sv) | 1986-04-07 |
GB2055800A (en) | 1981-03-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NL180420C (nl) | Farmaceutische preparaten, welke een invloed op de maagzuurafscheiding bezitten en ten minste een guanidinothiazoolderivaat als werkzame stof bevatten alsmede de voor gebruik in dergelijke preparaten geschikte guanidinothiazoolderivaten. | |
NL7709073A (nl) | Insekticidepreparaat en werkwijze voor de bereiding daarvan. | |
NL7904235A (nl) | Klemconstructie, in het bijzonder voor een ashoes. | |
NL7713656A (nl) | Afgifte-orgaan voor biologisch actieve middelen. | |
NL7905375A (nl) | Prostanoiden, werkwijze voor het bereiden daarvan, en daarop gebaseerde farmaceutische preparaten. | |
NL183080C (nl) | Farmaceutisch preparaat, dat een (+)-catecholderivaat als werkzame stof bevat alsmede het voor gebruik in een dergelijk preparaat geschikte (+)-catecholderivaat. | |
NL7714066A (nl) | 1.4-dihydropyridineverbindingen, werkwijze voor de bereiding daarvan en farmaceutische prepara- ten, die deze verbindingen bevatten. | |
NL171985C (nl) | Werkwijze voor het bereiden van preparaten met werking tegen schistosomiasis, de aldus verkregen gevormde preparaten en werkwijze voor het bereiden van 1,2-dithioolverbindingen. | |
NL7802248A (nl) | Tetrahydrofuranether-derivaten, werkwijze voor het bereiden ervan alsmede toepassing ervan als herbicide. | |
NL7601085A (nl) | Werkwijze voor het bereiden van oxadiazolinon- -verbindingen, werkwijze voor het bereiden van preparaten met een insekticide, acaricide en nematocide werking, alsmede de gevormde prepa- raten. | |
NL7700702A (nl) | 1,2-benzisothiazolinonen-3, werkwijze voor het bereiden ervan, alsmede de toepassing ervan als geneesmiddel. | |
NL180664C (nl) | 1,8-alkyleen-3-carboxy-4-oxo-7-piperazinochinolinederivaten, werkwijze voor de bereiding daarvan en anti-microbiele preparaten die een dergelijke verbinding als werkzame stof bevatten. | |
NL187069C (nl) | N-acyl 3-(1-amino-3-methylbutyl)-8-hydroxy-3,4-dihydro-isocoumarine verbinding, werkwijze voor de bereiding daarvan en farmaceutisch preparaat. | |
NL187397C (nl) | Farmaceutische preparaten, 20,21-dinoreburnamenineverbindingen daarvoor en werkwijze voor hun bereiding. | |
NL175524C (nl) | Glycerolderivaten, deze bevattende farmaceutische preparaten, en werkwijze voor het bereiden daarvan. | |
NL176265C (nl) | Pyridoxolderivaat, werkwijze voor de bereiding daarvan en farmaceutische preparaten met diuretische en de nieren beschermende werking die deze verbinding bevatten. | |
NL7909200A (nl) | N-gesubstitueerde trifluorethylaminen, farmaceutische preparaten met als werkzaam bestanddeel een dergelijk n-gesubstitueerd trifluorethylamine erin, alsmede werkwijzen voor de bereiding van de werkzame bestand- delen. | |
NL7811135A (nl) | Digesubstitueerde piperazinen, werkwijze voor de bereiding ervan en geneesmiddelen met dergelijke verbindingen erin als werkzaam bestanddeel. | |
NL7704190A (nl) | Nieuwe acaricide en insecticide stoffen, en werkwijze voor de bereiding daarvan. | |
NL7801391A (nl) | Herbicidepreparaten en werkwijze voor de bereiding ervan. | |
NL7902449A (nl) | 3-0-(beta-d-glucuronopyranosyl)-sojasapogenol b en zouten daarvan, farmaceutische preparaten die deze verbindingen bevatten alsmede werkwijzen voor de berei- ding van de genoemde verbindingen. | |
NL7802826A (nl) | Thienamycinederivaat, werkwijze voor het bereiden daarvan, alsmede farmaceutische preparaten. | |
NL7802380A (nl) | Benzylpyrimidinen, een werkwijze voor de berei- ding daarvan en farmaceutische preparaten die deze verbindingen bevatten. | |
NL7901251A (nl) | Werkwijze voor het bereiden van een optisch actief ben- zamide, het op deze wijze verkregen optisch actieve benzamide en farmaceutische preparaten die deze ver- binding bevatten. | |
NL7811765A (nl) | Een biologische stof, werkwijze voor de bereiding ervan en geneesmiddel met een dergelijke biologische stof als werkzaam bestanddeel. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A1C | A request for examination has been filed | ||
A85 | Still pending on 85-01-01 | ||
BK | Erratum |
Free format text: CORRECTION TO PAMPHLET |
|
AC1 | Application for a supplementary protection certificate |
Free format text: 930038, 930519 |
|
KC1 | Grant of a supplementary protection certificate |
Free format text: 930038, 991227, EXPIRES:20020709 |
|
V4 | Discontinued because of reaching the maximum lifetime of a patent |
Free format text: 19991227 |